Pharmaceutical formulations of desmopressin

US9919025B2 · kind B2 · utility

Assignee

• Ferring B.V. · NL

Inventors

• Anders Nilsson · Västerås, SE
• Hans Lindner · Leichlingen, DE
• Jørgen Wittendorff · Copenhagen, DK

Key dates

• Filing date: Oct 25, 2016
• Grant date: Mar 20, 2018
• Expiry date: Oct 25, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/2095
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described herein are orodispersible pharmaceutical dosage forms of desmopressin comprising desmopressin free base or a pharmaceutically acceptable salt thereof, and one or more carriers, wherein at least one carrier is hydrolyzed gelatin in an open matrix network structure. Also described are methods of making and using such desmopressin orodispersible pharmaceutical dosage forms.